デフォルト表紙
市場調査レポート
商品コード
1193040

臨床リスク分類ソリューション市場:製品別、デプロイメント別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年

Clinical Risk Grouping Solutions Market By Product, By Deployment, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

出版日: | 発行: Allied Market Research | ページ情報: 英文 290 Pages | 納期: 2~3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=151.55円
臨床リスク分類ソリューション市場:製品別、デプロイメント別、エンドユーザー別:世界の機会分析および産業予測、2021-2031年
出版日: 2022年10月01日
発行: Allied Market Research
ページ情報: 英文 290 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の臨床リスク分類ソリューション市場は、2021年に4億1500万米ドルと評価され、2031年には16億3556万米ドルに達すると予測され、2022年から2031年にかけて14.6%のCAGRを記録しています。

臨床リスク分類ソリューションは、入院および外来診断・処置コード、医薬品記録、人口統計データを機能的健康状態と共に使用して個人を区別しグループ化し、将来のヘルスケア予測のために各個人を特定のリスクグループに割り当てるために使用されるシステムです。

臨床リスク分類ソリューション市場の成長は、がん、糖尿病、心血管疾患、高血圧などの慢性疾患の有病率の驚くべき増加、バーチャルヘルスサービスの利用の増加、ヘルスケア分野の技術の進歩、遠隔医療ソリューションの採用急増が主な要因となっています。また、ヘルスケア業界における患者のリスク管理への注目度の高まりや、臨床リスクグループ化のための高度なソリューションの採用が増加していることも、市場の成長を後押ししています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場の概要

  • 市場の定義と範囲
  • 主な調査結果
    • 主な投資ポケット
  • ポーターのファイブフォース分析
  • 主要企業のポジショニング
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
  • COVID-19 影響分析

第4章 臨床リスク分類ソリューション市場:製品別

  • 概要
    • 市場規模および予測
  • データ可視化ツール
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別分析
    • データ可視化ツール・臨床リスク分類ソリューション市場:タイプ別
      • ソフトウェア市場規模・予測:地域別
      • サービス市場規模・予測: 地域別
  • データアナリティクス
    • 主な市場動向、成長要因、機会
    • 市場規模・予測: 地域別
    • 市場分析: 国別

第5章 臨床リスク分類ソリューション市場:デプロイメント別

  • 概要
    • 市場規模・予測
  • プライベートクラウド
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別分析
  • パブリッククラウド
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • ハイブリッドクラウド
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第6章 臨床リスク分類ソリューション市場: エンドユーザー別

  • 概要
    • 市場規模・予測
  • ヘルスケアサービスプロバイダー
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別
  • 医療費支払者
    • 主な市場動向、成長要因、機会
    • 市場規模・予測:地域別
    • 市場分析:国別

第7章 臨床リスク分類ソリューション市場: 地域別

  • 概要
    • 市場規模・予測
  • 北米
    • 主な動向と機会
    • 北米の市場規模・予測:製品別
      • 北米のデータ可視化ツール・臨床リスク分類ソリューション市場:タイプ別
    • 北米市場規模・予測:デプロイメント別
    • 北米市場規模・予測:エンドユーザー別
    • 北米市場規模・予測:国別
      • 米国
      • カナダ
      • メキシコ
  • 欧州
    • 主な動向と機会
    • 欧州の市場規模・予測:製品別
      • 欧州のデータ可視化ツール・臨床リスク分類ソリューション市場:タイプ別
    • 欧州市場規模・予測:デプロイメント別
    • 欧州市場規模・予測:エンドユーザー別
    • 欧州市場規模・予測:国別
      • ドイツ
      • フランス
      • 英国
      • イタリア
      • スペイン
      • その他欧州
  • アジア太平洋地域
    • 主な動向と機会
    • アジア太平洋地域の市場規模・予測:製品別
      • アジア太平洋地域のデータ可視化ツール・臨床リスク分類ソリューション市場:タイプ別
    • アジア太平洋地域の市場規模・予測:デプロイメント別
    • アジア太平洋地域の市場規模・予測:エンドユーザー別
    • アジア太平洋地域の市場規模・予測:国別
      • 日本
      • 中国
      • オーストラリア
      • インド
      • その他アジア太平洋地域
  • LAMEA
    • 主な動向と機会
    • LAMEAの市場規模・予測:製品別
      • LAMEAのデータ可視化ツール・臨床リスク分類ソリューション市場:タイプ別
    • LAMEAの市場規模・予測:デプロイメント別
    • LAMEAの市場規模・予測:エンドユーザー別
    • LAMEAの市場規模・予測:国別
      • ブラジル
      • サウジアラビア
      • 南アフリカ
      • LAMEAの残りの地域

第8章 企業情勢

  • イントロダクション
  • 主要成功戦略
  • 主要10社の製品マッピング
  • 競合ダッシュボード
  • 競合のヒートマップ
  • 主な発展

第9章 企業プロファイル

  • Conduent Inc
  • 3M Corporation
  • Optum, Inc
  • Cerner Corporation
  • Nuance Communications
  • Health Catalyst, Inc
  • HBI Solutions
  • Johns Hopkins University
  • Lightbeam Health Solutions
  • Dynamic Healthcare Systems
図表

LIST OF TABLES

  • TABLE 1. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 2. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR DATA VISUALIZATION TOOLS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 3. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR DATA VISUALIZATION TOOLS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 4. GLOBAL DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 5. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR SOFTWARE, BY REGION, 2021-2031 ($MILLION)
  • TABLE 6. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR SERVICES, BY REGION, 2021-2031 ($MILLION)
  • TABLE 7. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR DATA ANALYTICS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 8. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR DATA ANALYTICS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 9. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 10. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR PRIVATE CLOUD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 11. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR PRIVATE CLOUD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 12. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR PUBLIC CLOUD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 13. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR PUBLIC CLOUD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 14. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR HYBRID CLOUD, BY REGION, 2021-2031 ($MILLION)
  • TABLE 15. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HYBRID CLOUD, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 16. GLOBAL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 17. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR HEALTHCARE SERVICE PROVIDERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 18. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HEALTHCARE SERVICE PROVIDERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 19. CLINICAL RISK GROUPING SOLUTIONS MARKET, FOR HELTHCARE PAYERS, BY REGION, 2021-2031 ($MILLION)
  • TABLE 20. CLINICAL RISK GROUPING SOLUTIONS MARKET FOR HELTHCARE PAYERS, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 21. CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION, 2021-2031 ($MILLION)
  • TABLE 22. NORTH AMERICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 23. NORTH AMERICA DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 24. NORTH AMERICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 25. NORTH AMERICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 26. NORTH AMERICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 27. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 28. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 29. U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 30. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 31. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 32. CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 33. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 34. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 35. MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 36. EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 37. EUROPE DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 38. EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 39. EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 40. EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 41. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 42. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 43. GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 44. FRANCE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 45. FRANCE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 46. FRANCE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 47. UK CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 48. UK CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 49. UK CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 50. ITALY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 51. ITALY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 52. ITALY CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 53. SPAIN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 54. SPAIN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 55. SPAIN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 56. REST OF EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 57. REST OF EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 58. REST OF EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 59. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 60. ASIA-PACIFIC DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 61. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 62. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 63. ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 64. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 65. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 66. JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 67. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 68. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 69. CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 70. AUSTRALIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 71. AUSTRALIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 72. AUSTRALIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 73. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 74. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 75. INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 76. REST OF ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 77. REST OF ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 78. REST OF ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 79. LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 80. LAMEA DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET, BY TYPE, 2021-2031 ($MILLION)
  • TABLE 81. LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 82. LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 83. LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
  • TABLE 84. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 85. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 86. BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 87. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 88. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 89. SAUDI ARABIA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 90. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 91. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 92. SOUTH AFRICA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 93. REST OF LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
  • TABLE 94. REST OF LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT, 2021-2031 ($MILLION)
  • TABLE 95. REST OF LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER, 2021-2031 ($MILLION)
  • TABLE 96.CONDUENT INC: COMPANY SNAPSHOT
  • TABLE 97.CONDUENT INC: OPERATING SEGMENTS
  • TABLE 98.CONDUENT INC: PRODUCT PORTFOLIO
  • TABLE 99.CONDUENT INC: NET SALES,
  • TABLE 100.CONDUENT INC: KEY STRATERGIES
  • TABLE 101.3M CORPORATION: COMPANY SNAPSHOT
  • TABLE 102.3M CORPORATION: OPERATING SEGMENTS
  • TABLE 103.3M CORPORATION: PRODUCT PORTFOLIO
  • TABLE 104.3M CORPORATION: NET SALES,
  • TABLE 105.3M CORPORATION: KEY STRATERGIES
  • TABLE 106.OPTUM, INC: COMPANY SNAPSHOT
  • TABLE 107.OPTUM, INC: OPERATING SEGMENTS
  • TABLE 108.OPTUM, INC: PRODUCT PORTFOLIO
  • TABLE 109.OPTUM, INC: NET SALES,
  • TABLE 110.OPTUM, INC: KEY STRATERGIES
  • TABLE 111.CERNER CORPORATION: COMPANY SNAPSHOT
  • TABLE 112.CERNER CORPORATION: OPERATING SEGMENTS
  • TABLE 113.CERNER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 114.CERNER CORPORATION: NET SALES,
  • TABLE 115.CERNER CORPORATION: KEY STRATERGIES
  • TABLE 116.NUANCE COMMUNICATIONS: COMPANY SNAPSHOT
  • TABLE 117.NUANCE COMMUNICATIONS: OPERATING SEGMENTS
  • TABLE 118.NUANCE COMMUNICATIONS: PRODUCT PORTFOLIO
  • TABLE 119.NUANCE COMMUNICATIONS: NET SALES,
  • TABLE 120.NUANCE COMMUNICATIONS: KEY STRATERGIES
  • TABLE 121.HEALTH CATALYST, INC: COMPANY SNAPSHOT
  • TABLE 122.HEALTH CATALYST, INC: OPERATING SEGMENTS
  • TABLE 123.HEALTH CATALYST, INC: PRODUCT PORTFOLIO
  • TABLE 124.HEALTH CATALYST, INC: NET SALES,
  • TABLE 125.HEALTH CATALYST, INC: KEY STRATERGIES
  • TABLE 126.HBI SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 127.HBI SOLUTIONS: OPERATING SEGMENTS
  • TABLE 128.HBI SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 129.HBI SOLUTIONS: NET SALES,
  • TABLE 130.HBI SOLUTIONS: KEY STRATERGIES
  • TABLE 131.JOHNS HOPKINS UNIVERSITY: COMPANY SNAPSHOT
  • TABLE 132.JOHNS HOPKINS UNIVERSITY: OPERATING SEGMENTS
  • TABLE 133.JOHNS HOPKINS UNIVERSITY: PRODUCT PORTFOLIO
  • TABLE 134.JOHNS HOPKINS UNIVERSITY: NET SALES,
  • TABLE 135.JOHNS HOPKINS UNIVERSITY: KEY STRATERGIES
  • TABLE 136.LIGHTBEAM HEALTH SOLUTIONS: COMPANY SNAPSHOT
  • TABLE 137.LIGHTBEAM HEALTH SOLUTIONS: OPERATING SEGMENTS
  • TABLE 138.LIGHTBEAM HEALTH SOLUTIONS: PRODUCT PORTFOLIO
  • TABLE 139.LIGHTBEAM HEALTH SOLUTIONS: NET SALES,
  • TABLE 140.LIGHTBEAM HEALTH SOLUTIONS: KEY STRATERGIES
  • TABLE 141.DYNAMIC HEALTHCARE SYSTEMS: COMPANY SNAPSHOT
  • TABLE 142.DYNAMIC HEALTHCARE SYSTEMS: OPERATING SEGMENTS
  • TABLE 143.DYNAMIC HEALTHCARE SYSTEMS: PRODUCT PORTFOLIO
  • TABLE 144.DYNAMIC HEALTHCARE SYSTEMS: NET SALES,
  • TABLE 145.DYNAMIC HEALTHCARE SYSTEMS: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 1.CLINICAL RISK GROUPING SOLUTIONS MARKET SEGMENTATION
  • FIGURE 2.CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031
  • FIGURE 3.CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031
  • FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
  • FIGURE 5.PORTER FIVE-1
  • FIGURE 6.PORTER FIVE-2
  • FIGURE 7.PORTER FIVE-3
  • FIGURE 8.PORTER FIVE-4
  • FIGURE 9.PORTER FIVE-5
  • FIGURE 10.TOP PLAYER POSITIONING
  • FIGURE 11.CLINICAL RISK GROUPING SOLUTIONS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 12.CLINICAL RISK GROUPING SOLUTIONS MARKET,BY PRODUCT,2021(%)
  • FIGURE 13.COMPARATIVE SHARE ANALYSIS OF DATA VISUALIZATION TOOLS CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 14.COMPARATIVE SHARE ANALYSIS OF DATA ANALYTICS CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 15.CLINICAL RISK GROUPING SOLUTIONS MARKET,BY DEPLOYMENT,2021(%)
  • FIGURE 16.COMPARATIVE SHARE ANALYSIS OF PRIVATE CLOUD CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PUBLIC CLOUD CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HYBRID CLOUD CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 19.CLINICAL RISK GROUPING SOLUTIONS MARKET,BY END USER,2021(%)
  • FIGURE 20.COMPARATIVE SHARE ANALYSIS OF HEALTHCARE SERVICE PROVIDERS CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 21.COMPARATIVE SHARE ANALYSIS OF HELTHCARE PAYERS CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031(%)
  • FIGURE 22.CLINICAL RISK GROUPING SOLUTIONS MARKET BY REGION,2021
  • FIGURE 23.U.S. CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 24.CANADA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 25.MEXICO CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 26.GERMANY CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 27.FRANCE CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 28.UK CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 29.ITALY CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 30.SPAIN CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 31.REST OF EUROPE CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 32.JAPAN CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 33.CHINA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 34.AUSTRALIA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 35.INDIA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 36.REST OF ASIA-PACIFIC CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 37.BRAZIL CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 38.SAUDI ARABIA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 39.SOUTH AFRICA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 40.REST OF LAMEA CLINICAL RISK GROUPING SOLUTIONS MARKET,2021-2031($MILLION)
  • FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 45.COMPETITIVE DASHBOARD
  • FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
  • FIGURE 47.CONDUENT INC.: NET SALES ,($MILLION)
  • FIGURE 48.3M CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 49.OPTUM, INC.: NET SALES ,($MILLION)
  • FIGURE 50.CERNER CORPORATION.: NET SALES ,($MILLION)
  • FIGURE 51.NUANCE COMMUNICATIONS.: NET SALES ,($MILLION)
  • FIGURE 52.HEALTH CATALYST, INC.: NET SALES ,($MILLION)
  • FIGURE 53.HBI SOLUTIONS.: NET SALES ,($MILLION)
  • FIGURE 54.JOHNS HOPKINS UNIVERSITY.: NET SALES ,($MILLION)
  • FIGURE 55.LIGHTBEAM HEALTH SOLUTIONS.: NET SALES ,($MILLION)
  • FIGURE 56.DYNAMIC HEALTHCARE SYSTEMS.: NET SALES ,($MILLION)
目次
Product Code: A08191

The global clinical risk grouping solutions market was valued at $415.0 million in 2021 and is projected to reach $1,635.56 million by 2031, registering a CAGR of 14.6% from 2022 to 2031.

The clinical risk grouping (CRG) solutions are a well-known system used for distinguishing and grouping individuals with the use of inpatient and ambulatory diagnosis and procedure codes, pharmaceutical records, and demographic data along with the functional health status to assign each individual to a specific risk group for future healthcare projections.

The growth of the clinical risk grouping solutions market is majorly driven by an alarming increase in the prevalence of chronic diseases, such as cancer, diabetes, cardiovascular disease, and hypertension; a rise in the use of virtual health services, advancement in technologies of the healthcare sector, and surge in adoption of telehealth solution. In addition, the increase in focus of the healthcare industry on patient risk management and the rise in the adoption of advanced solutions for clinical risk grouping boosts the growth of the market.

In addition, the increase in physician workload, the need for an efficient solution due to the explosion in patient pool data created in the healthcare industry, and the widespread usage of big data solutions contribute to the growth of the market. Moreover, an increase in R&D activities in cloud storage technology and a rise in the number of healthcare IT service providers foster the clinical risk grouping solutions market. Moreover, the introduction of artificial intelligence (AI) in the development of various healthcare software boosts the growth of the market.

The clinical risk grouping solutions market is segmented on the basis of product, deployment model, end user, and region. By product, the segment market is classified into data visualization tools and data analytics. The data visualization tools are further divided into software, and services.

Depending on the deployment model, it is classified into private cloud, public cloud, and hybrid cloud. Based on the end-user market is categorized into healthcare service providers and healthcare payers. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major companies profiled in the report include Cerner corporation, Microsoft corporation, Alibaba Group Holding Limited, IBM, Dundas Data Visualization, Inc, SAS, Klipfolio, Oracle Inc., Domo, Inc., Koch Industries, Qlik Technologies, Salesforce, SAP, Sisense, TIBCO, and Greenway.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the clinical risk grouping solutions market analysis from 2021 to 2031 to identify the prevailing clinical risk grouping solutions market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the clinical risk grouping solutions market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global clinical risk grouping solutions market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

  • Data Visualization Tools
    • Type
    • Software
    • services
  • Data Analytics

By Deployment

  • Private Cloud
  • Public Cloud
  • Hybrid Cloud

By End User

  • Healthcare service providers
  • Helthcare payers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
  • Key Market Players
    • Conduent Inc
    • 3M Corporation
    • Optum, Inc
    • Cerner Corporation
    • Nuance Communications
    • Health Catalyst, Inc
    • HBI Solutions
    • Johns Hopkins University
    • Lightbeam Health Solutions
    • Dynamic Healthcare Systems

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market

CHAPTER 4: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY PRODUCT

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Data Visualization Tools
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
    • 4.2.4 Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
      • 4.2.4.1 Software Market size and forecast, by region
      • 4.2.4.2 services Market size and forecast, by region
  • 4.3 Data Analytics
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country

CHAPTER 5: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY DEPLOYMENT

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Private Cloud
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
  • 5.3 Public Cloud
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Hybrid Cloud
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country

CHAPTER 6: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Healthcare service providers
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Helthcare payers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: CLINICAL RISK GROUPING SOLUTIONS MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Product
      • 7.2.2.1 North America Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.2.3 North America Market size and forecast, by Deployment
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Product
      • 7.2.5.1.2 Market size and forecast, by Deployment
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Product
      • 7.2.5.2.2 Market size and forecast, by Deployment
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Product
      • 7.2.5.3.2 Market size and forecast, by Deployment
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Product
      • 7.3.2.1 Europe Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.3.3 Europe Market size and forecast, by Deployment
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Product
      • 7.3.5.1.2 Market size and forecast, by Deployment
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Product
      • 7.3.5.2.2 Market size and forecast, by Deployment
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Product
      • 7.3.5.3.2 Market size and forecast, by Deployment
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Product
      • 7.3.5.4.2 Market size and forecast, by Deployment
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Product
      • 7.3.5.5.2 Market size and forecast, by Deployment
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Product
      • 7.3.5.6.2 Market size and forecast, by Deployment
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Product
      • 7.4.2.1 Asia-Pacific Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Deployment
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 Japan
      • 7.4.5.1.1 Market size and forecast, by Product
      • 7.4.5.1.2 Market size and forecast, by Deployment
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 China
      • 7.4.5.2.1 Market size and forecast, by Product
      • 7.4.5.2.2 Market size and forecast, by Deployment
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 Australia
      • 7.4.5.3.1 Market size and forecast, by Product
      • 7.4.5.3.2 Market size and forecast, by Deployment
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 India
      • 7.4.5.4.1 Market size and forecast, by Product
      • 7.4.5.4.2 Market size and forecast, by Deployment
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Product
      • 7.4.5.5.2 Market size and forecast, by Deployment
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Product
      • 7.5.2.1 LAMEA Data Visualization Tools Clinical Risk Grouping Solutions Market by Type
    • 7.5.3 LAMEA Market size and forecast, by Deployment
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Product
      • 7.5.5.1.2 Market size and forecast, by Deployment
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Product
      • 7.5.5.2.2 Market size and forecast, by Deployment
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Product
      • 7.5.5.3.2 Market size and forecast, by Deployment
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Product
      • 7.5.5.4.2 Market size and forecast, by Deployment
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Conduent Inc
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 3M Corporation
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Optum, Inc
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 Cerner Corporation
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 Nuance Communications
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Health Catalyst, Inc
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 HBI Solutions
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Johns Hopkins University
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Lightbeam Health Solutions
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Dynamic Healthcare Systems
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments